Dixon Hughes Goodman Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$483K	Buy	6,616 +1,550	+31%	+$104K	0.14%	104
2021 Q4	$316K	Buy	+5,066	New	+$297K	0.1%	110

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's BMY Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 31% in Q1 2022, buying an estimated $104K and bringing the position to 6,616 shares worth $483K. The position accounts for 0.14% of the portfolio, ranked #104.

Dixon Hughes Goodman Wealth Advisors first reported a position in BMY in Q4 2021 and has held it in 2 quarters since. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 6,616 shares of Bristol-Myers Squibb worth $483K as of Q1 2022.
Dixon Hughes Goodman Wealth Advisors bought 1,550 Bristol-Myers Squibb shares in Q1 2022, an estimated $104K.
Bristol-Myers Squibb made up 0.14% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #104 holding.
Dixon Hughes Goodman Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 2 quarters since.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.